In a global securities litigation marketplace with billions of dollars available to be recovered at any time, it is integral for investors to fully understand the implications to their firm.
Whether filing in-house, utilizing a third-party filer or Custodian Bank, or a hybrid approach, Recovery Solutions Capital assists investors to ensure that their recovery opportunities are represented and maximized.
These questions above, and many more, are ones each investor needs to ask themselves to make sure that every available recovery is maximized on your behalf. Investors oftentimes make assumptions as to what is being done by a vendor, and without a thorough review by knowledgeable people, potentially lost recovery opportunities are not identified.
Recovery Solutions Capital helps investors with one-time spot reviews of internal processes, Vendor Reviews, Due Diligence visits, RFI/RFPs, as well as overall organizational reviews for firms who may have multiple groups with disparate processes in place.
In January 2016, Merck & Co said it would pay $830 million to settle a …
In June 2016, BP Plc agreed to pay $175 million to shareholders who brought a …
In August 2016, Pfizer Inc. reached a $486 million settlement regarding a litigation case accusing …